CARE1 Pragmatic Clinical Trial

NCT06364631 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1250

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Kidney Cancer
Metastatic Kidney Carcinoma

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Pembrolizumab
DRUG: Cabozantinib
DRUG: Axitinib
DRUG: Lenvatinib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]